Management of dermatologic toxicities

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 13, Issue , 2015, Pages 686-689

  Lacouture, Mario E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ANTINEOPLASTIC AGENT;

ALOPECIA; CANCER RADIOTHERAPY; CANCER THERAPY; CONFERENCE PAPER; DISEASE ASSOCIATION; HAND FOOT SYNDROME; HUMAN; MANAGED CARE; PARONYCHIA; PRIMARY PREVENTION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; SKIN TOXICITY; CHEMICALLY INDUCED; DISEASE MANAGEMENT; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; NEOPLASMS; SKIN DISEASES;

ANTINEOPLASTIC AGENTS; DISEASE MANAGEMENT; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; NEOPLASMS; SKIN DISEASES;

EID: 84996551335     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2015.0204     Document Type: Conference Paper

References (15)

1. Boone SL, Rademaker A, Liu D, et al. Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: survey results. Oncology 2007;72:152-159.
2. Scope A, Agero AL, Dusza SW, et al. Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-Associated acne-like eruption. J Clin Oncol 2007;25:5390-5396.
3. Melosky BL, Handerson H, Burkes RL, et al. Pan-Canadian rash trial with EGFR inhibitors [abstract]. J Clin Oncol 2014;32(Suppl 5):Abstract 8013.
4. Lacouture ME, Mitchell EP, Piperdi B, et al. Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer. J Clin Oncol 2010;28:1351-1357.
5. Santini D, Vincenzi B, Guida FM, et al. Aprepitant for management of severe pruritus related to biological cancer treatments: A pilot study. Lancet Oncol 2012;13:1020-1024.
6. Zhang RX, Wu XJ, Lu SX, et al. The effect of COX-2 inhibitor on capecitabine-induced hand-foot syndrome in patients with stage II/III colorectal cancer: A phase II randomized prospective study. J Cancer Res Clin Oncol 2011;137:953-957.
7. Ren Z, Zhu K, Kang H, et al. Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-Associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma. J Clin Oncol 2015;33:894-900.
8. Roy I, Fortin A, Larochelle M. The impact of skin washing with water and soap during breast irradiation: A randomized study. Radiother Oncol 2001;58:333-339.
9. Miller RC, Schwartz DJ, Sloan JA, et al. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: A phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys 2011;79:1460-1466.
10. Morris CL, Stinnett S, Woodward J. The role of bimatoprost eyelash gel in chemotherapy-induced madarosis: An analysis of efficacy and safety. Int J Trichology 2011;3:84-91.
11. van den Hurk CJ, Peerbooms M, van de Poll-Franse LV, et al. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients: results of the Dutch Scalp Cooling Registry. Acta Oncol 2012;51:497-504.
12. Katsimbri P, Bamias A, Pavlidis N. Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. Eur J Cancer 2000;36:766-771.
13. Duvic M, Lemak NA, Valero V, et al. A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol 1996;35:74-78
14. Lacouture ME. Dr Lacoutures Skin Care Guide for People Living With Cancer. Cold Spring Harbor, NY: Harborside Press; 2012.
15. Lacouture, ME. Dermatologic Principles and Practice in Oncology. Hoboken, NJ Wiley-Blackwell 2014